Skip to the page

Data / Form D filings / RubyWell, Inc.

RubyWell, Inc.: Form D filing

RubyWell, Inc., a health care company in New York, NY, filed a Form D with the SEC in 2024. The latest, on October 18, 2024, reports $1.1 million sold of a $3 million offering to 12 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
712 FIFTH AVENUE, 7TH FLOOR, New York, NY, 10035
Phone
(646) 978-5596
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2024
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2041478

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 18, 2024New notice$3,000,000$1,110,000$1,890,00012Oct 1, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Michael LoebDirector
Abigail Miller LevyDirector
Julie KennedyExecutive Officer, Director

Other health care companies in New York that filed recently

Every Form D from the week of Oct 14, 2024 · All recent filings in New York · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what RubyWell, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.